The neuroprotective effect of treatment of valproic acid in acute spinal cord injury

Journal of Korean Neurosurgical Society

Volumn 51, Issue 4, 2012, Pages 191-198

  Yu, Song Hee ^a   Cho, Dae Chul ^a   Kim, Kyoung Tae ^a   Nam, Kyung Hun ^a   Cho, Hee Jung ^b   Sung, Joo Kyung ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Acetylation; Clip compression model; HDAC inhibitor; Spinal cord injury; Valproic acid

Indexed keywords

HISTONE H3; VALPROIC ACID;

ACUTE DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; GRAY MATTER; HISTONE ACETYLATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCOMOTION; MALE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; WHITE MATTER;

EID: 84862870942     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2012.51.4.191     Document Type: Article

References (57)

1. Balentine JD: Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab Invest 39: 236-253, 1978
2. Balentine JD: Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin. Lab Invest 39: 254-266, 1978
3. Basso DM, Beattie MS, Bresnahan JC: Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139: 244-256, 1996
4. Beattie MS: Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol Med 10: 580-583, 2004
5. Blaheta RA, Nau H, Michaelis M, Cinatl J Jr: Valproate and valproate-analogues: potent tools to fight against cancer. Curr Med Chem 9: 1417-1433, 2002
6. Blight AR, Young W: Central axons in injured cat spinal cord recover electrophysiological function following remyelination by Schwann cells. J Neurol Sci 91: 15-34, 1989
7. Bolden JE, Peart MJ, Johnstone RW: Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5: 769-784, 2006
8. Bracken MB, Collins WF, Freeman DF, Shepard MJ, Wagner FW, Silten RM, et al.: Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251: 45-52, 1984
9. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, et al.: Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277: 1597-1604, 1997
10. Brichta L, Holker I, Haug K, Klockgether T, Wirth B: In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann Neurol 59: 970-975, 2006
11. Celik M, GÖkmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, et al.: Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 99: 2258-2263, 2002
12. Chen PS, Wang CC, Bortner CD, Peng GS, Wu X, Pang H, et al.: Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 149: 203-212, 2007
13. Cho DC, Cheong JH, Yang MS, Hwang SJ, Kim JM, Kim CH: The effect of minocycline on motor neuron recovery and neuropathic pain in a rat model of spinal cord injury. J Korean Neurosurg Soc 49: 83-91, 2011
14. Cui SS, Yang CP, Bowen RC, Bai O, Li XM, Jiang W, Zhang X: Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats. Brain Res 975: 229-236, 2003
15. Dash PK, Orsi SA, Zhang M, Grill RJ, Pati S, Zhao J, et al.: Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS ONE 5: e11383, 2010
16. Faraco G, Pancani T, Formentini L, Mascagni P, Fossati G, Leoni F, et al.: Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol 70: 1876-1884, 2006
17. Feng HL, Leng Y, Ma CH, Zhang J, Ren M, Chuang DM: Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 155: 567-572, 2008
18. Fournier AE, Strittmatter SM: Repulsive factors and axon regeneration in the CNS. Curr Opin Neurobiol 11: 89-94, 2001
19. Fukuchi M, Nii T, Ishimaru N, Minamino A, Hara D, Takasaki I, et al.: Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci Res 65: 35-43, 2009
20. Giffard RG, Yenari MA: Many mechanisms for hsp70 protection from cerebral ischemia. J Neurosurg Anesthesiol 16: 53-61, 2004
21. Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, et al.: Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A 99: 9450-9455, 2002
22. GÖttlicher M, Minucci S, Zhu P, Krämer OH, Schimpf A, Giavara S, et al.: Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20: 6969-6978, 2001
23. Hall ED, Springer JE: Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 1: 80-100, 2004
24. Hashimoto R, Hough C, Nakazawa T, Yamamoto T, Chuang DM: Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem 80: 589-597, 2002
25. Heneka MT, Gavrilyuk V, Landreth GE, O'Banion MK, Weinberg G, Feinstein DL: Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression. J Neurochem 85: 387-398, 2003
26. Hsieh J, Gage FH: Chromatin remodeling in neural development and plasticity. Curr Opin Cell Biol 17: 664-671, 2005
27. Jeong MR, Hashimoto R, Senatorov VV, Fujimaki K, Ren M, Lee MS, et al.: Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett 542: 74-78, 2003
28. Kanai H, Sawa A, Chen RW, Leeds P, Chuang DM: Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Pharmacogenomics J 4: 336-344, 2004
29. Kazantsev AG, Thompson LM: Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7: 854-868, 2008
30. Khalatbary AR, Tiraihi T, Boroujeni MB, Ahmadvand H, Tavafi M, Tamjidipoor A: Effects of epigallocatechin gallate on tissue protection and functional recovery after contusive spinal cord injury in rats. Brain Res 1306: 168-175, 2010
31. Langley B, Gensert JM, Beal MF, Ratan RR: Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr Drug Targets CNS Neurol Disord 4: 41-50, 2005
32. Lee SM, Yune TY, Kim SJ, Park DW, Lee YK, Kim YC, et al.: Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma 20: 1017-1027, 2003
33. Li S, Strittmatter SM: Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci 23: 4219-4227, 2003
34. Li WW, Setzu A, Zhao C, Franklin RJ: Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 158: 58-66, 2005
35. Lin MS, Lee YH, Chiu WT, Hung KS: Curcumin provides neuroprotection after spinal cord injury. J Surg Res 166: 280-289, 2011
36. Nalivaeva NN, Belyaev ND, Turner AJ: Sodium valproate: an old drug with new roles. Trends Pharmacol Sci 30: 509-514, 2009
37. Ouyang YB, Giffard RG: Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function. Cell Calcium 36: 303-311, 2004
38. Pandey P, Saleh A, Nakazawa A, Kumar S, Srinivasula SM, Kumar V, et al.: Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J 19: 4310-4322, 2000
39. Pannu R, Barbosa E, Singh AK, Singh I: Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J Neurosci Res 79: 340-350, 2005
40. Penas C, Verdú E, Asensio-Pinilla E, Guzmán-Lenis MS, Herrando-Grabulosa M, Navarro X, et al.: Valproate reduces CHOP levels and preserves oligodendrocytes and axons after spinal cord injury. Neuroscience 178: 33-44, 2011
41. Peng W, Cotrina ML, Han X, Yu H, Bekar L, Blum L, et al.: Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci U S A 106: 12489-12493, 2009
42. Pérez M, Rojo AI, Wandosell F, Díaz-Nido J, Avila J: Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3. Biochem J 372: 129-136, 2003
43. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS: Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276: 36734-36741, 2001
44. Reckling JC: Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Neurosci Lett 335: 167-170, 2003
45. Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM: Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 89: 1358-1367, 2004
46. Rogawski MA, Löscher W: The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10: 685-692, 2004
47. Rowland JW, Hawryluk GW, Kwon B, Fehlings MG: Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 25: E2, 2008
48. Shin YC, Choi KY, Kim WG: Cyclosporin A has a protective effect with induced upregulation of Hsp70 and nNOS on severe spinal cord ischemic injury in rabbits. J Invest Surg 20: 113-120, 2007
49. Sinn DI, Kim SJ, Chu K, Jung KH, Lee ST, Song EC, et al.: Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol Dis 26: 464-472, 2007
50. Stepień K, Tomaszewski M, Czuczwar SJ: Neuroprotective properties of statins. Pharmacol Rep 57: 561-569, 2005
51. von Euler M, Seiger A, Sundström E: Clip compression injury in the spinal cord: a correlative study of neurological and morphological alterations. Exp Neurol 145: 502-510, 1997
52. Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM: Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 31: 52-57, 2011
53. Wells JE, Hurlbert RJ, Fehlings MG, Yong VW: Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126: 1628-1637, 2003
54. Yildirim F, Gertz K, Kronenberg G, Harms C, Fink KB, Meisel A, et al.: Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. Exp Neurol 210: 531-542, 2008
55. Young W: Secondary injury mechanisms in acute spinal cord injury. J Emerg Med 11 Suppl 1: 13-22, 1993
56. Yune TY, Kim SJ, Lee SM, Lee YK, Oh YJ, Kim YC, et al.: Systemic administration of 17beta-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 21: 293-306, 2004
57. Yune TY, Park HG, Lee JY, Oh TH: Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation. J Neurotrauma 25: 1121-1131, 2008